The World Health Organisation estimates that 30% of prescriptive drugs in circulation in emerging economies are counterfeit. Imagine you live in the developing world, and you depend upon regular medicine to keep you healthy enough to feed your family. There is roughly a one in three chance that each pill you take is at best ineffective, and at worst dangerous. Other than swallow and hope for the best, what can you do? …

I mentioned in an end 2011 article for GreenBiz, on Simon Mainwaring’s view of Contributory Consumption, that I’d had the opportunity to visit the LIVESTRONG Foundation HQ in Austin, TX as part of a series of Sustainable Life Media meetings last month hosted by Dell.

I was in Texas while COP 17 was playing out in Durban, so it may be the coincidence of timing leading me to make a connection, but I have been pondering similarities between society’s struggles to defeat cancer to the battle against global warming. Is there a lesson here?

The Lancet recently published a major international study revealing that 347 million adults worldwide suffered from diabetes in 2008 – a number that has doubled since 1980 and exceeds that shown in previous studies. As it was a scientific study, it doesn’t address the staggering economic implications of this number in terms of lost productivity and exorbitant healthcare costs for treatment and support. However, a study also published in June in Value in Health contends that nearly one in five people with diabetes are regularly unable to attend a full day at work due to disruption caused by episodes of dangerously low blood sugar. And one in every ten healthcare dollars in the US is spent on diabetes and its complications.

There are some days it feels like we are tinkering around the edges of a world that has gone mad.